Primary angiosarcoma of the pleura is an extremely rare tumour arising from arterial or venous pulmonary vessels of various size. It is characterized by an aggressive course and a poor prognosis. The early diagnosis is challenging due to diverse clinical and radiological manifestations. We report a case of a 70 year old male with primary right pleural epitheloid angiosarcoma. The patient had a history of a two week's progressive dyspnea. CTscan showed a prominent thikening of the right pleura associated with pleural effusion and atelectasis. CT-scan guided by biopsy was performed and histological examination showed a tumor proliferation consisting of sheets of polygonal and epitheloid cells showing rudimentary vascular differentiation. Immunohistochemically, tumor cells were strongly positive for CD31 and Factor VIII-related antigen, negative for CD34, weakly and focally positive for EMA and Cytokeratine. The overall pathological and immunohistochemical features of the pleural specimens supported the diagnosis of epitheloid angiosarcma. The patient died after a week of discharge by pulsless ventricular tachycardia arrest. In addition, we also present a brief litterature review on pleural angiosarcoma. Our experience with this case suggests that comprehensive and sufficient sample collection and meticulous histological examination aided with immunohistochemical stains, particulary the endothelial markers, are required for accurate diagnosis of this rare malignancy.
Introduction
Angiosarcoma is a very uncommon neoplasm derived from endothelial cells. It represents 1% to 2% of all soft tissue malignancies. The most frequent locations are skin and soft tissues. Primary pleural angiosarcoma is extremely rare; only 50 cases have been reported in the literature until 2010 [1] [2] [3] . Herein, we report a case of primary epitheloid angiosarcoma of the right pleura in a 70 years old man who had a two-weeks-history of progressive dyspnea and increase of abdominal lower limb volume. In addition, a literature review on pleural angisarcoma is included. can be present in variable proportions [15, 16] . The epitheloid variant accounts for 75% of the pleural angoisarcomas [3, 12] . It is often misdiagnosed as mesothelioma or adenocarcimoma [3] . Epitheloid histological variant is deemed to be an element of higher malignant potential when compared to the classical histological variant [16] . The interest of the immuno-histochemical study is crucial to distinguish the pleural angiosarcoma, from the other histologically-related neoplasms, like mesothelioma and adenocarcinoma [1, 3] .
Patient and observation
The epithelial markers (Cytokeratin, EMA), are always strongly expressed in the mesothelioma and the adenocarcinoma, whereas they are seldom expressed in the pleural angiosarcoma, and more particularly in the epitheloid variant [15] . However, both benign and malignant vascular tumors frequently express CK7 and CK14.
Published studies have reported that EAGS was positive for CK8 and CK18 in approximately 50% of cases, with positivity of more than 30% of tumor cells [17] . Thus, it's important, for differential diagnosis, to consider expression of CK which is either strongly or weakly expressed The CD31 would be of close, the most sensitive and the most specific vascular marker, which rarely react with non-vascular tumors [2, 3, 18] . While CD34, is less specific and sensitive marker and can be expressed by other soft tissue neoplasms, in particular the solitary fibrous tumors, dermatofibrosarcoma protuberans, myofibroblastomas, epitheloid sarcomas, gastrointestinal stromal tumors, neural tumors and spindle cell lipomas [2, [17] [18] [19] [20] . Factor VIIIrelated antigen often lacks immunoreactivty in vascular tumors [10] Folpe et al. [19] , reported that the FLI-1 was expressed by 50 vascular tumours (94%) out of 53, including 20 case of angiosarcomas among 22: this study highlighted the interesting role of the FLI-1 as new nuclear marker of vascular tumors. According to the published studies, the expression of at least one endothelial marker is necessary to confirm the diagnosis of angiosarcoma. Though the CD31 is regarded as being the most specific marker and the most sensitive. In our case, the tumour showed a diffuse intense expression of both the CD31 and the factor VIII-related antigen. There was no expression of the CD34.
In addition, a weak and focal expression of the epithelial antigen (EMA) and the cytokeratin; these lead to confirm the vascularepitheloid character. Therapeutic management is based on the surgery, and radio-chemotherapy [3, 12, 18] . The vascular embolization could reduce tumor volume and reduce the bleeding, and can be realized before the surgery [19, 20] . Surgery by far is the treatment of choice for localised lesions. The radiotherapy could play a beneficial role into postoperative in the absence of diffuse lesions [12, 19, 20] . Chemotherapy has few effects, and it is generally used as palliative treatment [3] . Unfortunately, our patient died one
week after evacuation of his pleural effusion, by cardiac arrest following a ventricular tachycardia, followed by asystole.
Conclusion
In conclusion, pleural angiosarcoma is a very rare aggressive malignancy with fast fatal outcome, regardless of the various therapeutic methods. The diagnosis requires a meticulous morphological analysis, supplemented imperatively by an immunohistochemical study, including mandatory the use of vascular markers. Table 1 : antibodies used in the current study and results 
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